BRIEF-Amgen pleads guilty to misbranding drugs - federal court hearing

Tue Dec 18, 2012 10:28am EST

Dec 18 (Reuters) - Amgen Inc : * Pleads guilty to misbranding drugs - federal court hearing in Brooklyn, New York * Agrees to pay $612 million for civil settlement, $14 million forfeiture, $136

million criminal fine * Misbranding charge involves marketing of anemia drug aranesp

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.